COMP <GO>
INTA vs CLBT // PIOTROSKI F-SCORE QUALITY
Intapp Inc. (NASDAQ) VS. Cellebrite DI Ltd. (NASDAQ) • 15-METRIC TALLY: INTA 0
— CLBT 10
▲ PIOTROSKI F-SCORE QUALITY LEADER: CLBT
LAST: $39.10 (-3.07%) • MKT CAP: $3.00B
piotroski-score
7/9
LAST: $12.28 (+3.02%) • MKT CAP: $3.09B
piotroski-score
8/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INTA VS. CLBT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | INTA | CLBT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 74.00% | 84.20% | -10.20 | CLBT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -9.90% | 14.60% | -24.50 | CLBT | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 38.1x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.07% | 5.19% | -1.12 | CLBT | /fcf-yield <GO> |
| Operating Margin | -5.40% | 14.00% | -19.40 | CLBT | /operating-margins <GO> |
| Net Profit Margin | -3.60% | 16.50% | -20.10 | CLBT | /net-margins <GO> |
| Revenue Growth (YoY) | 17.10% | 18.60% | -1.50 | CLBT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.00 | 4.95 | -0.95 | CLBT | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 7/9 | 8/9 | -1.00 | CLBT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.5 | 58.1 | -5.65 | CLBT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 33.1x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.00B | $3.09B | -$89.4M | CLBT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | INTA REV | CLBT REV | INTA GROSS % | CLBT GROSS % | INTA FCF | CLBT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $504.1M | $475.7M | 74.0% | 84.2% | $121.9M | $160.3M |
| FY 2024 | $430.5M | $401.2M | 71.3% | 84.4% | $64.8M | $123.6M |
| FY 2023 | $350.9M | $325.1M | — | — | $27.5M | $102.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INTA // BETA —
CLBT // BETA —